United Pharmacy Partners inks Novation deal for PET isotopes

United Pharmacy Partners (UPPI) of Suwanee, Ga., has signed a five-year agreement with Novation, a healthcare supply chain and contracting company, to offer PET radiopharmaceuticals.

UPPI said its radiopharmacies can supply radiopharmaceutical products for both diagnostic and therapeutic uses to assist members in servicing their patients' needs. Novation provides sourcing services, as well as information and data services to healthcare providers in the U.S.

In addition to providing both low and high radioisotopes to the member sites served by Novation, UPPI said it will offer support options to those members. UPPI will offer quality programs in the areas of continuing education and reimbursement support which can include hotline support, webinars, facility audits, healthcare reform consulting and accreditation assistance. BioDose Patient Management Systems, the patient management system which allows the technologists to capture patient data, manage patient studies, electronically order/fax doses plus many more tasks is also available to members, according to the pharmacy.

The agreement commenced on July 1, and will be in place for five years.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.